Tribunal Upholds Commissioner's Decision on Cenvat Credit Exemption

The Tribunal upheld the Commissioner's decision, ruling that the respondent was not required to reverse the Cenvat credit upon opting for exemption under Notification No. 50/2003-C.E. The Tribunal emphasized the precedence of the High Court's decision over the Tribunal's decision and cited the relevance of previous decisions by the Larger Bench of the Tribunal. The appeal by the Revenue was rejected, affirming the Commissioner's decision in favor of the respondent.

---

---

Issues:
- Whether the respondent was required to reverse the Cenvat credit on inputs and finished goods/semi-finished goods upon opting for exemption under Notification No. 50/2003-C.E.
- Preference between the decisions of the Hon'ble High Court and the Tribunal.
- Applicability of the decision in the case of Saboo Alloys.
- Consideration of the Larger Bench's decision in the case of HMT and Apco Pharma Ltd.

Analysis:

The main issue in the present appeal was whether the respondent had to reverse the Cenvat credit on inputs and goods upon opting for exemption under Notification No. 50/2003-C.E. The Commissioner (Appeals) allowed the appeal of the respondent, citing the decision of the Hon'ble Himachal Pradesh High Court in the case of Saboo Alloys P. Ltd. The Commissioner held that the input credit was not required to be reversed by the respondent, following the Saboo Alloys case.

The Revenue contended that the Commissioner erred in giving precedence to the High Court's decision over the Tribunal's decision in the case of Ranbaxy Lab. Ltd. The Revenue argued that the Tribunal's decision was subsequent to the High Court's decision and that the Saboo Alloys case was referred to by the Tribunal in its order. However, the Tribunal found no merit in the Revenue's contention, stating that the High Court's decision should be given preference over the Tribunal's decision due to the hierarchy of courts.

Furthermore, the Tribunal addressed the Revenue's reliance on the Ranbaxy Lab. Ltd. case, stating that the Tribunal cannot find faults in the judgments of High Courts. The Tribunal emphasized that if the issue involved is the same, the declaration of law by the High Court must be followed. Additionally, the Tribunal noted that the issue had been decided by the Larger Bench of the Tribunal in the case of HMT and Apco Pharma Ltd., where it was held that input credit legally taken and utilized on dutiable final products need not be reversed upon the final product becoming exempt.

In conclusion, the Tribunal upheld the Commissioner's decision, rejecting the Revenue's appeal. The Tribunal emphasized the precedence of the High Court's decision over the Tribunal's decision and highlighted the relevance of previous decisions by the Larger Bench of the Tribunal in similar matters.

---